LondonMetric Property acquires six single let urban logistics properties for £78.0 million

LMP

LondonMetric Property Plc (LON:LMP) has announced the off market acquisition of six single let urban logistics properties for £78.0 million from a FSTE 100 pension fund. The purchase price reflects a blended NIY of 5.8% which rises to 6.9% over the next two years.

The Portfolio comprises six high quality properties totalling 526,000 sq ft, located in Stafford, Banbury, Romford, Southampton, Bristol and Aberdeen. It is leased to strong tenants including General Electric, Thales, EVRI, Macarthys Laboratories and KCA Deutag, with a WAULT of 10 years.

The Portfolio generates income of £4.8 million p.a., equating to an average rent of £9.20 psf, which is expected to rise to £5.8 million p.a. (£11.10 psf) over the next two years.

Separately, LondonMetric has sold a further office asset in Edinburgh for £6.0 million. It is let to HSBC for a further five years’ term certain and was acquired through the CTPT takeover. LondonMetric has now sold 14 of the 16 non core CTPT assets at an average of 18% above original underwrite values.

Andrew Jones, Chief Executive of LondonMetric, commented:

“This was a very rare opportunity to acquire, off market, a high quality portfolio which is immediately earnings accretive. The well located, mission critical assets, offer an attractive mix of near term income growth and value-enhancing asset management opportunities.

“Logistics remains our strongest conviction thematic and now accounts for over 45% of our total portfolio.”

LondonMetric Property was advised by Cortex Partners and the seller was advised by Clay Street.

Share on:

Latest Company News

Likewise expands distribution capacity to support its next growth phase

Likewise is expanding its Yorkshire and Newport distribution capacity as it builds the infrastructure needed to support its next stage of growth.

EDX Medical builds scale through Scottish Prostate Cancer Testing programme

EDX Medical is expanding its role in a 25,000-participant Scottish programme testing a more targeted approach to prostate cancer detection.

James Cropper reports stronger FY26 profit and reduced net debt

James Cropper delivered a 3.6% rise in revenue to £102.9m and increased adjusted EBITDA by 33% to £8.9m, supported by record Advanced Materials sales, improved Paper & Packaging performance and lower net debt.

Convatec names NED and outlines CFO transition

Convatec has outlined finance leadership changes, appointed Tobias Hestler as a Non-Executive Director and reaffirmed its 2026 expectations.

Rio Tinto maintains 2026 guidance as iron ore sales and lithium output rise

Rio Tinto reported higher first-half copper equivalent production, with stronger copper and lithium output and unchanged full-year guidance.

Cizzle Biotechnology reports US accreditation and patent progress in H1 2026

Cizzle Biotechnology entered its commercialisation phase during the first half of 2026 after securing CLIA accreditation for its CIZ1B early lung cancer test in the U.S. The company also strengthened its North American patent position and increased guaranteed minimum royalty receipts to approximately US$5.9 million.

    Search